Aclaris Therapeutics Inc (ACRS)
1.195
+0.02
(+2.14%)
USD |
NASDAQ |
Apr 25, 16:00
1.195
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Cash from Operations (Quarterly): -6.761M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.761M |
| September 30, 2023 | -24.56M |
| June 30, 2023 | -20.65M |
| March 31, 2023 | -26.35M |
| December 31, 2022 | -19.12M |
| September 30, 2022 | -7.817M |
| June 30, 2022 | -19.67M |
| March 31, 2022 | -20.97M |
| December 31, 2021 | -17.08M |
| September 30, 2021 | -10.61M |
| June 30, 2021 | -12.22M |
| March 31, 2021 | -12.23M |
| December 31, 2020 | -8.857M |
| September 30, 2020 | -12.15M |
| June 30, 2020 | -10.82M |
| March 31, 2020 | -6.805M |
| December 31, 2019 | -20.39M |
| September 30, 2019 | -23.36M |
| Date | Value |
|---|---|
| June 30, 2019 | -21.38M |
| March 31, 2019 | -31.32M |
| December 31, 2018 | -27.25M |
| September 30, 2018 | -29.86M |
| June 30, 2018 | -21.83M |
| March 31, 2018 | -21.87M |
| December 31, 2017 | -18.21M |
| September 30, 2017 | -13.71M |
| June 30, 2017 | -10.08M |
| March 31, 2017 | -12.66M |
| December 31, 2016 | -8.072M |
| September 30, 2016 | -9.905M |
| June 30, 2016 | -9.732M |
| March 31, 2016 | -6.894M |
| December 31, 2015 | -4.137M |
| September 30, 2015 | -10.57M |
| June 30, 2015 | -2.862M |
| March 31, 2015 | -2.802M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-26.35M
Minimum
Mar 2023
-6.761M
Maximum
Dec 2023
-15.88M
Average
-17.08M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| Aldeyra Therapeutics Inc | 0.5004M |
| Akoya Biosciences Inc | -5.584M |
| MSP Recovery Inc | -8.49M |
| Bullfrog AI Holdings Inc | -1.018M |
| Cadrenal Therapeutics Inc | -0.6944M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 7.55M |
| Cash from Financing (Quarterly) | 0.049M |
| Free Cash Flow | -79.63M |
| Free Cash Flow Per Share (Quarterly) | -0.1016 |
| Free Cash Flow to Equity (Quarterly) | -7.202M |
| Free Cash Flow Yield | -95.47% |